YECO Stock Price, Chart, Stats & News

EV Biologics, Inc.
Save
EV Biologics, Inc. (YECO) does not currently pay a dividend.
2,890
Market cap
–
Current P/E
–
Forward P/E
YECO chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its proprietary, versatile EV platform to engineer innovative vaccines, treatments, and potential cures. Beyond EVs, it also dedicates efforts to cultivating human mesenchymal and other stem cells, as well as various cell-derived products, to address the needs of the cosmetic and biopharmaceutical industries.
Similar securities
Based on sector and market capitalization
Report issue





